Korea University
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.korea.ac.kr
Clinical Trials
129
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (102 trials with phase data)• Click on a phase to view related trials
Ultra-processed Food Reducing Intervention and Continuous Glucose Monitoring
- Conditions
- Glucose Level ChangeGlycemic VariabilityPostprandial GlucoseGlucose LevelsGlycemic ControlGlucoseHyperglycemiasGlucose IntoleranceFood Additives
- First Posted Date
- 2025-09-16
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- Korea University
- Target Recruit Count
- 40
- Registration Number
- NCT07175701
- Locations
- 🇰🇷
Health Promotion Lab, College of Health Science, Korea University, Seoul, Seoul, South Korea
Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
- Conditions
- Metabolic Dysfunction-Associated Steatotic Liver DiseaseCardiovascular Diseases
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Korea University
- Target Recruit Count
- 6000
- Registration Number
- NCT06843421
- Locations
- 🇰🇷
Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeong-si, Korea, Republic of
🇰🇷Yonsei University Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of
🇰🇷Inje Univerisity Sanggye Paik Hospital, Seoul, Nowon-gu, Korea, Republic of
Improving Executive Function in Korean Children With Autism
- Conditions
- Autism Spectrum Disorder
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Korea University
- Target Recruit Count
- 40
- Registration Number
- NCT06523660
- Locations
- 🇰🇷
Korea University, Seoul, Korea, Republic of
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma
- Conditions
- SurveillanceHepatocellular CarcinomaLiver Cirrhosis
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Korea University
- Target Recruit Count
- 1418
- Registration Number
- NCT04414956
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of
🇰🇷The Catholic University of Korea Uijeongbu St.Mary's Hospital, Uijeongbu, Gyeonggi-do, Korea, Republic of
🇰🇷Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: Switching to Generic Entecavir (Baracle®)
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Korea University
- Target Recruit Count
- 40
- Registration Number
- NCT04069858
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
News
Seer Launches Next-Generation Proteomics Platform Enabling Unprecedented 20,000-Sample Cancer Study
Seer's new Proteograph ONE Assay and SP200 Automation Instrument can process over 1,000 samples per week, doubling throughput while reducing per-sample costs by approximately 60% compared to 2021.